ADD – How do the two approaches to treating high-risk smoldering multiple myeloma (HRSMM) patients differ?

In this weeks video, Dr. Brian G.M. Durie compares two trials that treat high-risk smoldering multiple myeloma the CESAR trial and the CENTAURUS trial.

BOTTOM LINE:

The IMFs Black Swan Research Initiative is excited about the CESAR trial and will conduct future trials in hopes of achieving a cure for myeloma.